Impairment of Brucella growth in human macrophagic cells that produce nitric oxideGROSS, Antoine; BERTHOLET, Sylvie; MAUEL, Jacques et al.Microbial pathogenesis. 2004, Vol 36, Num 2, pp 75-82, issn 0882-4010, 8 p.Article

Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvantGOTO, Yasuyuki; BOGATZKI, Lisa Y; BERTHOLET, Sylvie et al.Vaccine. 2007, Vol 25, Num 42, pp 7450-7458, issn 0264-410X, 9 p.Article

Evaluation of the Safety and Immunogenicity in Rhesus Monkeys of a Recombinant Malaria Vaccine for Plasmodium vivax with a Synthetic Toll-Like Receptor 4 Agonist Formulated in an EmulsionLUMSDEN, Joanne M; PICHYANGKUL, Sathit; SATTABONGKOT, Jetsumon et al.Infection and immunity. 2011, Vol 79, Num 9, pp 3492-3500, issn 0019-9567, 9 p.Article

Antigen-specific cellular and humoral responses are induced by intradermal Mycobacterium leprae infection of the mouse earDUTHIE, Malcolm S; REECE, Stephen T; REED, Steven G et al.Infection and immunity. 2007, Vol 75, Num 11, pp 5290-5297, issn 0019-9567, 8 p.Article

The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effectCALABRO, Samuele; TRITTO, Elaine; PEZZOTTI, Annamaria et al.Vaccine. 2013, Vol 31, Num 33, pp 3363-3369, issn 0264-410X, 7 p.Article

Optimized subunit vaccine protects against experimental leishmaniasisBERTHOLET, Sylvie; GOTO, Yasuyuki; CARTER, Lauren et al.Vaccine. 2009, Vol 27, Num 50, pp 7036-7045, issn 0264-410X, 10 p.Article

Leishmania donovani-induced expression of suppressor of cytokine signaling 3 in human macrophages: a novel mechanism for intracellular parasite suppression of activationBERTHOLET, Sylvie; DICKENSHEETS, Harold L; SHEIKH, Faruk et al.Infection and immunity. 2003, Vol 71, Num 4, pp 2095-2101, issn 0019-9567, 7 p.Article

Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responsesGALLORINI, Simona; TACCONE, Marianna; BONCI, Alessandra et al.Vaccine. 2014, Vol 32, Num 20, pp 2382-2388, issn 0264-410X, 7 p.Article

A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1 + MPL-SE vaccine when used in combination with sodium stibogluconate for the treatment of mucosal leishmaniasisLLANOS-CUENTAS, Alejandro; CALDERON, Wessmark; BECKMANN, Anna Marie et al.Vaccine. 2010, Vol 28, Num 46, pp 7427-7435, issn 0264-410X, 9 p.Article

Enhanced humoral and Type 1 cellular immune responses with Fluzone^® adjuvanted with a synthetic TLR4 agonist formulated in an emulsionBALDWIN, Susan L; SHAVERDIAN, Narek; REED, Steven G et al.Vaccine. 2009, Vol 27, Num 43, pp 5956-5963, issn 0264-410X, 8 p.Article

Intradermal immunization improves protective efficacy of a novel TB vaccine candidateBALDWIN, Susan L; BERTHOLET, Sylvie; KAHN, Maria et al.Vaccine. 2009, Vol 27, Num 23, pp 3063-3071, issn 0264-410X, 9 p.Article

Antigen requirements for efficient priming of CD8⁺ T cells by Leishmania major-infected dendritic cellsBERTHOLET, Sylvie; DEBRABANT, Alain; AFRIN, Farhat et al.Infection and immunity. 2005, Vol 73, Num 10, pp 6620-6628, issn 0019-9567, 9 p.Article